The Soluble Transferrin Receptor (TfR)-F-Index Is Not Applicable as a Test for Iron Status in Patients With Chronic Lymphocytic Leukemia

Clinical Chemistry and Laboratory Medicine - Germany
doi 10.1515/cclm.2009.273
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Walter de Gruyter GmbH

Related search

Soluble Form of Transferrin Receptor as a Biomarker of Ineffective Erythropoiesis and Iron Overload in Pediatric Egyptian Patients With B-Thalassemia

The Medical Journal of Cairo University
2019English

Soluble Transferrin Receptor as a Marker of Erythropoiesis in Patients Undergoing High-Flux Hemodialysis

Bosnian Journal of Basic Medical Sciences
Medicine
2017English

A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia.

Blood
BiochemistryImmunologyCell BiologyHematology
2009English

Nursing Guidelines for Managing Infections in Patients With Chronic Lymphocytic Leukemia

Clinical Journal of Oncology Nursing
Oncology
2007English

Soluble Serum Transferrin Receptor (STFR) Levels in Hemodialysis Patients

Annals of King Edward Medical University
2016English

Targeting the B Cell Receptor Pathway in Chronic Lymphocytic Leukemia

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2012English

936 Soluble Transferrin Receptor as a Marker of Iron Stores in Fullterm and Preterm Newborns and Infants

Pediatric Research
Child HealthPediatricsPerinatology
2010English

Evaluation of Iron Status in Patients of Chronic Kidney Disease - A Study to Assess the Best Indicators Including Serum Transferrin Receptor Assay

2019English

Circulating VE-cadherin in Patients With Controlled Chronic Lymphocytic Leukemia

Pathologia
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy